Skip to main content
Advertisement
  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Genetics
    • Neuroimmunology & Neuroinflammation
    • Education
  • Online Sections
    • COVID-19
    • Inclusion, Diversity, Equity, Anti-racism, & Social Justice (IDEAS)
    • Innovations in Care Delivery
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • Topics A-Z
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Null Hypothesis
    • Patient Pages
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Editorial Boards
    • Contact Us
  • Authors
    • Submit a Manuscript
    • Author Center

Advanced Search

Main menu

  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Genetics
    • Neuroimmunology & Neuroinflammation
    • Education
  • Online Sections
    • COVID-19
    • Inclusion, Diversity, Equity, Anti-racism, & Social Justice (IDEAS)
    • Innovations in Care Delivery
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • Topics A-Z
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Null Hypothesis
    • Patient Pages
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Editorial Boards
    • Contact Us
  • Authors
    • Submit a Manuscript
    • Author Center
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Resident & Fellow Section

User menu

  • Subscribe
  • My Alerts
  • Log in

Search

  • Advanced search
American Academy of Neurology Journals
Home
  • Subscribe
  • My Alerts
  • Log in
Site Logo

Insurance

Latest Articles

  • Research
    Association Between Pharmacy Benefit Restrictions and Disease-Modifying Therapy Use in the Medicare Part D Program
    Daniel M. Hartung, Kirbee A. Johnston, Jessina C. McGregor, et al.
    Neurology: Clinical Practice July 27, 2021
  • Special Article
    Decisions With Patients and Families Regarding Aducanumab in Alzheimer Disease, With Recommendations for ConsentAAN Position Statement
    Winston Chiong, Benjamin David Tolchin, Richard J. Bonnie, et al.
    Neurology November 17, 2021
  • Commentary
    Tackling Quality—It's Never a Level Playing Field: Companion Piece to the Neurology Outcome Measure Set
    Brian Cabaniss, Korwyn Williams, Meghan Ward, et al.
    Neurology: Clinical Practice January 20, 2022
  • Article
    The economic impact of glioma survivorshipThe cost of care from a patient perspective
    Sameah A. Haider, Karam Asmaro, Steven N. Kalkanis, et al.
    Neurology July 09, 2020
Show more
Advertisement
  • Neurology Podcast - Over 16 million downloads!
    Neurodegeneration in Pro Football Players: TBI/CTE
    Dr. Shuvro Roy talks with Dr. Ann McKee about her career and work studying the consequences of repetitive traumatic brain injury (TBI) and chronic traumatic encephalopathy (CTE).
    May 26, 2022
    Neurology, Journal, Podcast
    Listen19:14
    Subscribe
    View Recent Podcasts
Site Logo
  • Neurology
  • Neurology: Clinical Practice
  • Neurology: Genetics
  • Neurology: Neuroimmunology & Neuroinflammation
  • Neurology: Education
  • AAN.com
  • AANnews
  • Continuum
  • Brain & Life
  • Neurology Today

Wolters Kluwer Logo

© 2022 American Academy of Neurology

  • Privacy Policy
  • Feedback
  • Advertise